Rebeck GW - Search Results

1

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, Staehelin H, Growdon JH, Tanzi RE, Hyman BT. Liao A, et al. Among authors: rebeck gw. Hum Mol Genet. 1998 Nov;7(12):1953-6. doi: 10.1093/hmg/7.12.1953. Hum Mol Genet. 1998. PMID: 9811940

2

Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

West HL, Rebeck GW, Hyman BT. West HL, et al. Among authors: rebeck gw. Neurosci Lett. 1994 Jul 4;175(1-2):46-8. doi: 10.1016/0304-3940(94)91074-x. Neurosci Lett. 1994. PMID: 7970208

3

Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.

Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW. Hyman BT, et al. Among authors: rebeck gw. Ann N Y Acad Sci. 1996 Jan 17;777:158-65. doi: 10.1111/j.1749-6632.1996.tb34414.x. Ann N Y Acad Sci. 1996. PMID: 8624079 Review.

4

A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.

Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT. Mui S, et al. Among authors: rebeck gw. Neurology. 1996 Jul;47(1):196-201. doi: 10.1212/wnl.47.1.196. Neurology. 1996. PMID: 8710077

5

Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.

Clatworthy AE, Gomez-Isla T, Rebeck GW, Wallace RB, Hyman BT. Clatworthy AE, et al. Among authors: rebeck gw. Arch Neurol. 1997 Oct;54(10):1289-92. doi: 10.1001/archneur.1997.00550220087019. Arch Neurol. 1997. PMID: 9341576

6

Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease.

Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. Hollenbach E, et al. Among authors: rebeck gw. Neurology. 1998 Jun;50(6):1905-7. doi: 10.1212/wnl.50.6.1905. Neurology. 1998. PMID: 9633759

7

Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons.

Qiu Z, Strickland DK, Hyman BT, Rebeck GW. Qiu Z, et al. Among authors: rebeck gw. J Neurochem. 1999 Oct;73(4):1393-8. doi: 10.1046/j.1471-4159.1999.0731393.x. J Neurochem. 1999. PMID: 10501182 Free article.

8

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

Hyman BT, Strickland D, Rebeck GW. Hyman BT, et al. Among authors: rebeck gw. Arch Neurol. 2000 May;57(5):646-50. doi: 10.1001/archneur.57.5.646. Arch Neurol. 2000. PMID: 10815129 Review.

9

Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients.

Guénette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE, Blacker D. Guénette SY, et al. Among authors: rebeck gw. Neurosci Lett. 2000 Dec 15;296(1):17-20. doi: 10.1016/s0304-3940(00)01607-4. Neurosci Lett. 2000. PMID: 11099823

10

No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease.

Bertram L, Guénette S, Jones J, Keeney D, Mullin K, Crystal A, Basu S, Yhu S, Deng A, Rebeck GW, Hyman BT, Go R, McInnis M, Blacker D, Tanzi R. Bertram L, et al. Among authors: rebeck gw. Ann Neurol. 2001 Jan;49(1):114-6. doi: 10.1002/1531-8249(200101)49:1<114::aid-ana18>3.0.co;2-m. Ann Neurol. 2001. PMID: 11198280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters